Share on StockTwits

CVS Caremark (NYSE:CVS) declared a quarterly dividend on Thursday, July 10th, American Banking and Market News reports. Investors of record on Monday, July 21st will be given a dividend of 0.275 per share on Friday, August 1st. This represents a $1.10 dividend on an annualized basis and a yield of 1.43%.

Several analysts have recently commented on the stock. Analysts at Susquehanna raised their price target on shares of CVS Caremark from $85.00 to $90.00 in a research note on Friday, June 6th. They now have a “positive” rating on the stock. On the ratings front, analysts at Zacks reiterated a “neutral” rating on shares of CVS Caremark in a research note on Thursday, May 29th. They now have a $81.00 price target on the stock. Finally, analysts at Deutsche Bank raised their price target on shares of CVS Caremark from $80.00 to $83.00 in a research note on Wednesday, May 28th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $77.21.

Shares of CVS Caremark (NYSE:CVS) traded down 0.29% during mid-day trading on Thursday, hitting $76.62. 1,592,128 shares of the company’s stock traded hands. CVS Caremark has a 1-year low of $56.32 and a 1-year high of $79.43. The stock has a 50-day moving average of $76.90 and a 200-day moving average of $73.21. The company has a market cap of $89.875 billion and a price-to-earnings ratio of 19.57.

CVS Caremark (NYSE:CVS) last posted its quarterly earnings results on Friday, May 2nd. The company reported $1.02 EPS for the quarter, missing the Thomson Reuters consensus estimate of $1.05 by $0.03. The company had revenue of $32.70 billion for the quarter, compared to the consensus estimate of $32.31 billion. During the same quarter in the prior year, the company posted $0.22 earnings per share. The company’s quarterly revenue was up 6.3% on a year-over-year basis. Analysts expect that CVS Caremark will post $4.46 EPS for the current fiscal year.

In other CVS Caremark news, CFO David M. Denton sold 74,989 shares of the stock on the open market in a transaction that occurred on Tuesday, July 1st. The shares were sold at an average price of $75.88, for a total value of $5,690,165.32. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

CVS Caremark Corporation (NYSE:CVS), together with its subsidiaries, is a pharmacy health care provider in the United States.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.